within Pharmacolibrary.Drugs.ATC.V;

model V09CX01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 340 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,
    adminCount     = 1,
    Vd             = 0.00019,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Sodium iodohippurate labeled with iodine-123 (123I) is a radiopharmaceutical used primarily in nuclear medicine for diagnostic renal imaging to assess renal plasma flow and kidney function. It is not a therapeutic agent and is intended for imaging and diagnostic procedures. It is currently approved for use in diagnostic renal scintigraphy.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for adults with normal renal function following intravenous administration for diagnostic purposes.</p><h4>References</h4><ol><li><p>Oriuchi, N, et al., &amp; Endo, K (1996). Evaluation of gamma camera-based measurement of individual kidney function using iodine-123 orthoiodohippurate. <i>European journal of nuclear medicine</i> 23(4) 371â€“375. DOI:<a href=&quot;https://doi.org/10.1007/BF01247363&quot;>10.1007/BF01247363</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8612655/&quot;>https://pubmed.ncbi.nlm.nih.gov/8612655</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V09CX01;
